drugset / Trial / NCT05285566
Pain Control for Undergoing Costal Cartilage Harvesting
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE®.
Timeline
- Start
- 2022-05-04
- Primary completion
- 2026-08
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 106 mg | Subcutaneous |
| Comparator | Lidocaine | Other / unclassified | 8 ml | — |